| View Larger Image | Cancer Drug Design and Discovery | Hardcoverby Stephen Neidle (Editor)
| List Price: | $94.95 | | Price: | $85.42 | | You Save: | $9.53 (10%) | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Academic Press | | Edition: | 1st Edition | | Page Count: | 496 Pages | | Publication Date: | November 28, 2007 | | Sales Rank: | 761,693st |
|
EDITORIAL REVIEWS |
Product Description
The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development* Provides a clinical perspective on trials of new anticancer agents* Presents drug discovery examples through the use of case histories |
SIMILAR PRODUCTS |
| Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization
by Edward Kerns (Author), Li Di (Author)
Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, typically only a fraction of these have sufficient ADME/Tox properties to become a drug product. Understanding ADME/Tox is critical for all drug researchers, owing to its increasing importance in advancing high quality candidates to clinical studies and the processes of drug discovery. If the properties are weak, the candidate will have a high risk of failure or be less...
| 
| Drugs: From Discovery to Approval
by Rick Ng (Author)
“Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.” –Doody's Reviews, May 2009 "The second edition of a book that offers a user-friendly step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical trials." –Chemistry World, February 2009
The new edition of...
| 
| Molecules That Changed the World
by K. C. Nicolaou (Author), Tamsyn Montagnon (Author)
In this delightfully designed book, K. C. Nicolaou introduces the world's most important molecules and shows in a fascinating way the role certain compounds have to play in our everyday lives in the fields of drugs, aromatics or vitamins. For example, he tells the story of Aspirin, beginning 3,500 years ago in Egypt, through to its first synthesis and various applications with many entertaining facts and details. Printed in full color throughout and with its oversize format, this is a must for...
| 
| The Practice of Medicinal Chemistry, Third Edition
by Camille Georges Wermuth (Editor)
Now in its third edition, this classic reference is the one-stop-shop for information on the foundations of medicinal chemistry for pharmaceutical researchers who are involved in drug development & discovery but who do not have a background in medicinal chemistry. Wermuth aids pharmaceutical researchers and chemists in making faster, more accurate identifications of the active substances that could potentially treat the disorder they are researching. New chapters on Drug Absorption & Transport...
| 
| Structure-based Drug Discovery
by Harren Jhoti (Author), Harren Jhoti;Andrew Leach (Editor)
Discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission. Structure-based drug discovery methods have been transformed in the last 5-10 years and are now having a major impact on the discovery of new drugs. Some of the most exciting developments in the field, such as Fragment-based methods, are described in this book. The book describes the latest developments in technologies that can be used to...
|
|
|
